Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juris J Meier

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
Nature Reviews. Endocrinology|September 5, 2012
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitusJuris J Meier
Critical Care (London, England)|October 5, 2010
Waking up the gut in critically ill patientsJuris J Meier
Deutsche Medizinische Wochenschrift (1946)|April 30, 2015
[Glucose-lowering therapy in patients with cardiac comorbidities]Juris J Meier
Frontiers in Endocrinology|July 12, 2021
Efficacy of Semaglutide in a Subcutaneous and an Oral FormulationJuris J Meier
Best Practice & Research. Clinical Endocrinology & Metabolism|September 15, 2009
The contribution of incretin hormones to the pathogenesis of type 2 diabetesJuris J Meier
Current Opinion in Gastroenterology|July 1, 2015
Diabetes associated with pancreatic diseasesJuris J Meier, Arnd Giese
Best Practice & Research. Clinical Endocrinology & Metabolism|November 10, 2004
Clinical endocrinology and metabolism. Glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptideJuris J Meier, Michael A Nauck
Annals of Internal Medicine|December 5, 2012
Diagnostic accuracy of an "amended" insulin-glucose ratio for the biochemical diagnosis of insulinomasMichael A Nauck, Juris J Meier
European Journal of Endocrinology|October 11, 2019
MANAGEMENT OF ENDOCRINE DISEASE: Are all GLP-1 agonists equal in the treatment of type 2 diabetes?Michael A Nauck, Juris J Meier
Diabetes, Obesity & Metabolism|January 25, 2018
Incretin hormones: Their role in health and diseaseMichael A Nauck, Juris J Meier
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
Nature Reviews. Endocrinology|September 5, 2012
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitusJuris J Meier
Critical Care (London, England)|October 5, 2010
Waking up the gut in critically ill patientsJuris J Meier
Deutsche Medizinische Wochenschrift (1946)|April 30, 2015
[Glucose-lowering therapy in patients with cardiac comorbidities]Juris J Meier
Frontiers in Endocrinology|July 12, 2021
Efficacy of Semaglutide in a Subcutaneous and an Oral FormulationJuris J Meier
Best Practice & Research. Clinical Endocrinology & Metabolism|September 15, 2009
The contribution of incretin hormones to the pathogenesis of type 2 diabetesJuris J Meier
Current Opinion in Gastroenterology|July 1, 2015
Diabetes associated with pancreatic diseasesJuris J Meier, Arnd Giese
Best Practice & Research. Clinical Endocrinology & Metabolism|November 10, 2004
Clinical endocrinology and metabolism. Glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptideJuris J Meier, Michael A Nauck
Annals of Internal Medicine|December 5, 2012
Diagnostic accuracy of an "amended" insulin-glucose ratio for the biochemical diagnosis of insulinomasMichael A Nauck, Juris J Meier
European Journal of Endocrinology|October 11, 2019
MANAGEMENT OF ENDOCRINE DISEASE: Are all GLP-1 agonists equal in the treatment of type 2 diabetes?Michael A Nauck, Juris J Meier
Diabetes, Obesity & Metabolism|January 25, 2018
Incretin hormones: Their role in health and diseaseMichael A Nauck, Juris J Meier
Pageof 15